Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
-
Published:2019-10
Issue:10
Volume:30
Page:1613-1621
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Weiss J.M.ORCID, Csoszi T., Maglakelidze M., Hoyer R.J., Beck J.T., Domine Gomez M., Lowczak A., Aljumaily R., Rocha Lima C.M., Boccia R.V., Hanna W., Nikolinakos P., Chiu V.K., Owonikoko T.K., Schuster S.R., Hussein M.A., Richards D.A., Sawrycki P., Bulat I., Hamm J.T., Hart L.L., Adler S., Antal J.M., Lai A.Y., Sorrentino J.A., Yang Z., Malik R.K., Morris S.R., Roberts P.J., Dragnev K.H.
Funder
G1 Therapeutics Inc
Subject
Oncology,Hematology
Cited by
121 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|